Does ENZALUTAMIDE Cause Treatment failure? 116 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 116 reports of Treatment failure have been filed in association with ENZALUTAMIDE (Xtandi). This represents 0.2% of all adverse event reports for ENZALUTAMIDE.
116
Reports of Treatment failure with ENZALUTAMIDE
0.2%
of all ENZALUTAMIDE reports
5
Deaths
10
Hospitalizations
How Dangerous Is Treatment failure From ENZALUTAMIDE?
Of the 116 reports, 5 (4.3%) resulted in death, 10 (8.6%) required hospitalization.
Is Treatment failure Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENZALUTAMIDE. However, 116 reports have been filed with the FAERS database.
What Other Side Effects Does ENZALUTAMIDE Cause?
Fatigue (8,891)
Death (6,680)
Malignant neoplasm progression (4,696)
Prostatic specific antigen increased (3,731)
Asthenia (3,589)
Drug ineffective (3,468)
Hot flush (3,144)
Decreased appetite (3,069)
Nausea (2,898)
Dizziness (2,776)
What Other Drugs Cause Treatment failure?
METHOTREXATE (14,672)
ETANERCEPT (11,893)
ADALIMUMAB (9,990)
ABATACEPT (9,301)
RITUXIMAB (9,217)
TOCILIZUMAB (9,097)
HYDROXYCHLOROQUINE (8,786)
LEFLUNOMIDE (8,686)
INFLIXIMAB (8,535)
SULFASALAZINE (7,423)
Which ENZALUTAMIDE Alternatives Have Lower Treatment failure Risk?
ENZALUTAMIDE vs EPCORITAMAB
ENZALUTAMIDE vs EPCORITAMAB-BYSP
ENZALUTAMIDE vs EPERISONE
ENZALUTAMIDE vs EPHEDRINE
ENZALUTAMIDE vs EPINASTINE